Keywords: european, plavix, patent, challenge, sanofi-aventis, blockbuster, blood-thinning
European Plavix patent challenge for Sanofi-Aventis
Article | 31 January 2005
Sanofi-Aventis' blockbuster blood-thinning agent Plavix (clopidogrel), already under patent challenge in the USA from Canada's Apotex and India's Dr Reddy's ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
